Ketamine Therapy vs Antidepressants: Key Differences

Ketamine therapy differs from antidepressants because it targets different receptors and provides faster results, making it ideal for treatment-resistant depression. Find out more about what it involves.

Key Takeaways

• People seeking depression treatment should be aware of the different approaches, which generally include antidepressants and ketamine therapy.
• Compared to antidepressants, ketamine therapy is generally recommended for treatment-resistant depression. It works on different receptors and provides faster results.
• You should also consider differences in cost, insurance, administration, duration, side effects, and safety profile.

Table of Contents

• How Do Traditional Antidepressants Work?
• How Does Ketamine Treatment Work?
• What Are the Main Differences Between Ketamine Therapy and Antidepressants?
• Which Depression Treatment Is Right For Me?
• Futures Recovery Can Help You Make the Right Choice for Your Needs
• FAQs

Introduction

There is a rising interest in ketamine therapy for depression and other mental health disorders, but individuals should research carefully to ensure it’s the right choice for their needs, as compared to antidepressants. The main difference is the receptors ketamine targets and its ability to work quickly. It is also typically prescribed for treatment-resistant depression symptoms, where previous treatments have not been effective.

Learn more about what’s involved in both treatment options, so you can determine which is best suited to your needs.

How Do Traditional Antidepressants Work?

Antidepressants work by regulating brain chemistry through daily medication. They were developed based on the theory that depression stems from a deficiency of neurotransmitters, such as serotonin and norepinephrine, in the brain. These medications typically fall into a few main classes, as follows:

• Selective serotonin reuptake inhibitors (SSRIs): Block the reabsorption of serotonin in the brain, leaving more available to improve mood.
• Serotonin-norepinephrine reuptake inhibitors (SNRIs): Target both serotonin and norepinephrine reuptake, thereby increasing their availability for mood regulation.
• Other classes, including tricyclic antidepressants and MAOIs, are used less frequently today due to more challenging side effect profiles, but may still be prescribed when first-line options fail.

National Institute of Mental Health research reveals it can take clients six weeks to experience relief of depression symptoms when taking antidepressants, and seven weeks for full remission. And even then, outcomes were mixed: one-third of participants reached remission during the initial 12-14-week treatment period, with an additional 10-15% showing partial improvement without full remission.

How Does Ketamine Treatment Work?

Ketamine therapy works on the glutamate system with rapid onset and relief of depression symptoms. It is a non-competitive agonist of the NMDA receptor, blocking its channels and relieving mechanisms, inhibiting inhibitory neurons, and boosting excitatory activity by raising glutamate levels in the prefrontal cortex and hippocampus to improve mood.

The glutamate surge goes beyond temporary relief. It guides structural changes that promote the growth of neuronal dendrites and enhance neuroplasticity, yielding long-term effects. This mechanism is also believed to explain why ketamine guides a rapid response, often improving mood after a single dose.

Ketamine can be administered in various ways, as follows:

• Ketamine Infusion Therapy: Ketamine is administered via intravenous infusion in a clinical setting.
• Intramuscular Injection: An alternative route used by some clinics.
• Esketamine (nasal spray): The only FDA-approved ketamine treatment that provides relief at a lower dose.
• Oral Tablets: A home-based option that is less expensive than other treatments but may be less effective due to a lack of medical guidance.

What Are the Main Differences Between Ketamine Therapy and Antidepressants?

The main differences between ketamine therapy and antidepressants are the speed of onset and their mechanisms. However, there are other factors to consider, such as the conditions they treat, administration, duration and maintenance, side effects and safety, and cost and insurance considerations. The following sections will explain those differences in greater detail.

Treatment Recommendations

Ketamine is generally used for treatment-resistant depression, defined as depression that has not responded to at least two antidepressant trials, and major depressive disorder with suicidal thoughts and behavior. It may also treat PTSD, anxiety, bipolar depression, and some substance use disorders.

Antidepressants are typically a first-line treatment for depression and can also treat anxiety disorders.

Administration and Setting

Ketamine is typically administered in a clinical setting with careful monitoring. Clinical visits may occur twice weekly, once weekly, or once every two weeks, depending on treatment recommendations and the type of administration. While oral tablets may be taken at home, the lack of oversight often makes them less effective.

Antidepressants are taken daily. Clients typically see a psychiatrist regularly to ensure safe dosing.

Duration and Maintenance

The initial stages of ketamine therapy typically involve six infusions, which may be delivered over the course of 2-6 weeks, depending on individual needs. After that, booster sessions are typically recommended.

Antidepressants are taken daily on an ongoing basis.

Side Effects and Safety Profile

Less is known about the long-term effectiveness and psychological effects of frequent ketamine use compared to traditional antidepressants, for which there are extensive long-term studies confirming safety and efficacy. However, based on research, common side effects include visual and auditory hallucinations, dissociation, agitation, confusion, increased heart rate and blood pressure, nausea, cramps, and vomiting. Additionally, as a Schedule III drug, ketamine carries a potential risk for misuse and addiction, necessitating clinical supervision during its administration.

Traditional antidepressants can cause side effects such as weight gain, sexual dysfunction, emotional numbness, and withdrawal symptoms, which can be significant for some patients.

Cost and Insurance Considerations

Ketamine therapy and antidepressants follow very different payment models. Traditional antidepressants are typically billed as a fixed monthly prescription cost, often a $10–$50 copay under most insurance plans. Ketamine therapy, by contrast, is usually structured around a treatment series, a set number of sessions delivered over several weeks, followed by periodic maintenance visits, so the cost is front-loaded rather than spread out indefinitely.

Insurance coverage also depends heavily on formulation and FDA status. Esketamine (brand name Spravato) is FDA-approved for treatment-resistant depression and is billed under medical insurance, meaning many plans cover it with prior authorization and an in-network provider.

IV ketamine and compounded formulations, however, remain off-label for depression, which means coverage is inconsistent and many patients pay out of pocket.

For patients weighing the two options, it can help to think in terms of total treatment investment rather than per-dose price: a monthly antidepressant cost accumulates indefinitely, while ketamine’s cost is concentrated in an initial series. Some clinics offer package pricing, sliding-scale fees, or financing plans, and treatment costs are often HSA/FSA-eligible.

Which Depression Treatment Is Right For Me?

When determining which depression treatment is best, consider your treatment and medical history, the urgency of your situation, your ability to commit to treatment, other diagnoses, and the side effects, as follows:

• Have You Tried Multiple Antidepressants? Antidepressants are typically a first line of treatment. Ketamine therapy should only be considered when those treatment paths have failed.
• The Urgency of Your Situation: If you are experiencing suicidal thoughts, you may require a fast-acting treatment, like ketamine.
• Can You Commit to the Treatment Structure? Ketamine requires clinical visits and monitoring that may require you to take off work. You also need to arrange transportation to and from the clinic, as driving after treatment is not allowed.
• Do You Have Other Diagnoses? Ketamine is typically recommended for treatment-resistant depression. When depression co-exists alongside other conditions, you must consider which line of treatment is most suitable.
• How Do You Feel About the Side Effect Profile? Ketamine’s side effects are typically more intense but temporary, while antidepressant side effects are milder but ongoing.
• Do You Have Medical Contraindications? Both treatment methods may not be recommended for individuals with certain medical conditions.

Futures Recovery Can Help You Make the Right Choice for Your Needs

Futures Recovery of Tequesta, FL recognizes the importance of finding the right mental health treatment for your needs. We work with each patient and offer a wide variety of options across multiple recovery programs. Our integrated care team will attend to your specific needs to provide the best outcomes.

Contact us to learn more about our effective services and luxury accommodations.

FAQs

How quickly does each treatment start working?

Traditional antidepressants generally produce results in 6-7 weeks. Ketamine therapy can start working in 24 hours.

How long do ketamine’s effects last after treatment?

After a full infusion series, one randomized study found the median time to relapse among responders was 18 days from the last infusion, though duration varies considerably between individuals, and maintenance sessions are typically needed to sustain benefits over the longer term.

Can I take ketamine therapy and antidepressants together?

Yes. Esketamine is FDA-approved specifically to be used in conjunction with an oral antidepressant, not as a replacement for one, for its treatment-resistant depression indication.

Does ketamine treat anxiety or PTSD, not just depression?

Ketamine can treat anxiety and PTSD but is not FDA-approved for those conditions. Results may vary.

Why does ketamine work faster than antidepressants?

Antidepressants gradually raise serotonin/norepinephrine levels, taking weeks to provide symptom relief. Ketamine a rapid glutamate surge that promotes synaptic plasticity, believed to produce measurable brain changes within hours.

Sources

1. Mayo Clinic. “Serotonin and norepinephrine reuptake inhibitors (SNRIs).” https://www.mayoclinic.org/diseases-conditions/depression/in-depth/snris/art-20044970.
2. National Institute of Mental Health (NIMH). “Questions and Answers about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study — All Medication Levels.” https://www.nimh.nih.gov/funding/clinical-research/practical/stard/allmedicationlevels.
3. PMC (National Library of Medicine). “A Review of the Mechanism of Antagonism of N-methyl-D-aspartate Receptor by Ketamine in Treatment-resistant Depression.” https://pmc.ncbi.nlm.nih.gov/articles/PMC6051558/.
4. PMC (National Library of Medicine). “Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.” https://pmc.ncbi.nlm.nih.gov/articles/PMC4416968/.
5. PMC (National Library of Medicine). “Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381465/.
6. PMC (National Library of Medicine). “Esketamine for treatment resistant depression: a trick of smoke and mirrors?” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061126/.
7. PubMed (National Library of Medicine). “Role of Ketamine in the Treatment of Psychiatric Disorders.” https://pubmed.ncbi.nlm.nih.gov/35106397/.
8. PMC (National Library of Medicine). “Pharmacogenetics of SSRIs and Sexual Dysfunction.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034069/.
9. Annals of General Psychiatry (Springer Nature). “Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants.” https://link.springer.com/article/10.1186/s12991-023-00447-0.
10. ClinicalTrials.gov. “Ketamine for the Treatment of Opioid Use Disorder and Depression” (protocol document). https://cdn.clinicaltrials.gov/large-docs/06/NCT04177706/Prot_SAP_000.pdf.
11. PubMed (National Library of Medicine). “Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.” https://pubmed.ncbi.nlm.nih.gov/34363603/.
12. Frontiers in Pharmacology. “Comparative safety and tolerability of ketamine and esketamine for major depressive disorder: a systematic review and meta-analysis.” https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1681060/full.
13. PMC (National Library of Medicine). “Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression.” https://pmc.ncbi.nlm.nih.gov/articles/PMC3725185/.
14. PMC (National Library of Medicine). “Ketamine treatment for depression: a review.” https://pmc.ncbi.nlm.nih.gov/articles/PMC9010394/.